STAT

DECEMBER 14, 2023

Jay Bradner, a former top research leader at Novartis, is joining Amgen as its new chief scientific officer, the California company announced Thursday.   Reese is becoming the company’s chief technology officer.   Bradner is taking over for Amgen veteran David Reese in the role.

120

120

STAT

FEBRUARY 8, 2024

First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials.

108

108

Pharmaceutical Technology

FEBRUARY 15, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

FEBRUARY 14, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

European Pharmaceutical Review

FEBRUARY 8, 2024

Another driving factor shared in the research was technology advancement and the integration of digital technologies in the market. Automation, data analytics, and real-time monitoring are some of the approaches supporting more innovative and efficient rapid microbiology testing methods, the authors remarked.

83

83

Pharmaceutical Technology

FEBRUARY 15, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms and the gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Immunization 104

Immunization Pharmaceutical Companies Pharmaceutical Companies 104

European Pharmaceutical Review

NOVEMBER 28, 2023

billion, the research projected. Chiefly, innovations in biotechnology and precision medicine are generating a need for advanced cold storage infrastructure. One key technology solution is automation, the report observed. Therefore, by the end of 2032, the market will value an estimated $383.05

Compounding 94

Compounding Vaccines 94

Pharmaceutical Technology

FEBRUARY 14, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

STAT

SEPTEMBER 21, 2023

The prestigious Lasker Awards for biomedical research are sometimes referred to as “America’s Nobel,” and with good reason — about a fourth of Lasker laureates have gone on to receive the Swedish award, too. Read the rest…

106

106

pharmaphorum

JANUARY 3, 2024

Explore how GenAI is revolutionising clinical trials by bringing precision and innovation to the development of therapies. Learn how this technology is improving patient outcomes and advancing the field of clinical research.

58

58

European Pharmaceutical Review

MARCH 15, 2024

According to research published by Coherent Market Insights, the global mycoplasma testing market is anticipated to reach $1,907.6 Specifically, technology innovations such as sequencing technology, supported by “strong government funding for biomedical research” in the US has driven rapid developments in this area.

Compounding 87

Compounding 87

Pharmaceutical Technology

JUNE 4, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Mayo Clinic 98

Mayo Clinic Hospitals Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

NOVEMBER 1, 2022

FEATURED COMPANIES COMMENDED : • Innovation • Product Launch • Safety VIEW PROFILE COMMENDED : • Business Expansion • Innovation • Investments VIEW PROFILE COMMENDED: • Social VIEW PROFILE. The Excellence Rankings celebrate the greatest achievements and innovations in the industry. What is Research and Development (R&D)?

Vaccines 91

Vaccines 91

European Pharmaceutical Review

AUGUST 30, 2023

According to a report by Transparency Market Research Inc, the global cell and gene therapy (CGT) manufacturing quality control (QC) market is anticipated to value $2.8 This is due to the strong presence of research, biotechnology, and pharmaceutical industries, the report noted. billion in 2031. percent from 2023 to 2031.

93

93

Pharmaceutical Technology

FEBRUARY 14, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Immunization FDA 98

European Pharmaceutical Review

MARCH 6, 2023

Harwell, the UK’s leading science and innovation campus in Oxfordshire will be the location of the Moderna Innovation and Technology Centre (MITC). We’re proud to announce @HarwellCampus in Oxfordshire as the location of our new Moderna Innovation and Technology Centre (MITC) in the UK.

Vaccines 85

Vaccines FDA 85

European Pharmaceutical Review

NOVEMBER 23, 2022

The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU).

Documentation 101

Documentation 101

European Pharmaceutical Review

AUGUST 22, 2023

According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. The investment aims to improve vaccines and shorten the time it takes to produce medicines.

Vaccines 89

Vaccines Packaging 89

European Pharmaceutical Review

APRIL 28, 2023

While new approaches aim to solve the unique challenges of the sector, like adhering to strict compliance regulations, digitalisation has quickly developed into a pathway for achieving information technology (IT)/operational technology (OT) integration, edge-to-enterprise connectivity, and overall operational excellence.

92

92

Pharmaceutical Technology

MAY 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Hospitals 98

Hospitals Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

FEBRUARY 22, 2024

A key innovation method is the oral route of administration. Geographically, North America emerged as a key player, gaining a 38 percent share of the market in 2023, the research found. The year 2023 was “significant” for the progress of advanced drug delivery systems, the author reflected. Last year, with a size of $234.84

FDA 86

FDA 86

European Pharmaceutical Review

MARCH 27, 2024

With one success factor of Swedish life sciences being the export numbers, “in majority driven by AstraZeneca”, Maja Neiman, Scientific Director of SwedenBIO explained to EPR that another important influence is “the high numbers and potential of [Sweden’s] domestic innovation pipeline”.

86

86

European Pharmaceutical Review

JANUARY 12, 2024

New technologies at the facility will support the increased manufacturing capacity, the company stated on X. Furthermore, to prioritise innovation, Boehringer Ingelheim stated that in 2022, the company’s expenditure was €4.6 The expansion will boost exports of medicines from Greece to the US market.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

FEBRUARY 14, 2024

A report by Allied Market Research predicts that the global pharmaceutical suspension market will reach $83.8 billion in 2022, the research expected that the market will reach a CAGR of 4.2 billion by 2032. Having valued $55.5 percent between 2023 and 2032. It will therefore “maintain its dominance” by 2032.

74

74

European Pharmaceutical Review

MARCH 7, 2024

According to HM Treasury, the fund is designed “to build resilience for future health emergencies such as influenza pandemics and capitalise on the UK’s world-leading research and development.” Funding sustainable innovations In a separate statement, HM Treasury confirmed that AstraZeneca intends to invest a total of £650 million in the UK.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Packaging Vaccines 97

Pharmaceutical Technology

FEBRUARY 23, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Compounding 75

Compounding Pharmaceutical Companies Pharmaceutical Companies 75

STAT

APRIL 12, 2023

Last fall in STAT, Matt Herper questioned whether the biomedical research enterprise is really laying the necessary groundwork to gain the full benefit of innovation in “biology’s century.” Fox Foundation has been working to address just the biomedical research challenges Matt wrote about.

107

107

Pharmaceutical Technology

SEPTEMBER 13, 2022

Microsoft is offering AI technology, foundational science models and capabilities through collaboration. . To expedite Novo Nordisk's research and development (R&D), Microsoft is also collaborating with the former’s data researchers and domain specialists from initial research and development regions.

139

139

European Pharmaceutical Review

SEPTEMBER 7, 2023

Researchers can apply for grants and bid to take part in projects with certainty that the UK will be participating as a fully associated member until the deal reaches its end in 2027. Boosting collaboration and research for the UK life sciences sector Participation “unlocks access to the €95.5

80

80

European Pharmaceutical Review

MARCH 20, 2024

percent between 2022-2028, the research found. For example, Germany occupied a market share of 21 percent as it is considered the most research-intensive economy after the US and China. Based on the research, the US LIMS market is predicted to value $1 billion by 2028. million by 2028. The market is growing at a CAGR of 10.16

95

95

European Pharmaceutical Review

NOVEMBER 30, 2022

The UK-based Centre for Process Innovation (CPI) has opened its £88 million Medicines Manufacturing Innovation Centre in Glasgow, Scotland, to help accelerate medicine development by focusing on small molecule and fine chemical manufacturing and sustainable manufacturing. Investors of the Medicines Manufacturing Innovation Centre.

85

85

Pharma Mirror

DECEMBER 16, 2022

The COVID-19 pandemic challenged researchers to discover life-saving treatments at an unprecedented pace. While these researchers rose to the occasion by discovering drugs faster than ever before, variants continue to challenge the world in addressing COVID-19.

105

105

NICE

MARCH 30, 2023

Despite high levels of research expenditure, there is a lack of effective new treatments. In response, the Innovative Medicines Initiative (IMI) committed over €380 million on a diverse portfolio of more than 20 different research projects. These include conditions such as Alzheimer's, Parkinson's and multiple sclerosis.

97

97

Pharmaceutical Technology

APRIL 10, 2023

Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. The company strengthens the translational research collaboration between the US and Ireland.

Immunization 103

Immunization 103

European Pharmaceutical Review

FEBRUARY 13, 2023

Tokyo researchers have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA)-based medicines. The method is an important innovation for quality control ( QC) in production lines.

Immunization 103

Immunization Labelling Vaccines 103

Pharmaceutical Technology

MAY 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

European Pharmaceutical Review

APRIL 25, 2024

Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Additionally, advances in technology and a rising prevalence of chronic diseases were described as two factors that are helping to boost the market. This is because it causes innovation to slow and heightens expenses for manufacturers.

Packaging 75

Packaging Generic Medicine Vaccines 75